PLPZOTUM represents a high-potency injectable antibiotic formulation combining Piperacillin and Tazobactam in precise therapeutic ratios. Each vial contains Piperacillin Sodium USP...

PLPZOTUM represents a high-potency injectable antibiotic formulation combining Piperacillin and Tazobactam in precise therapeutic ratios. Each vial contains Piperacillin Sodium USP equivalent to 4 grams Piperacillin and Tazobactam Sodium equivalent to 500 milligrams Tazobactam, ensuring optimal antibacterial coverage. The product is designed for straightforward reconstitution with 20 milliliters of sterile water for Injection IP, facilitating immediate administration in time-sensitive medical situations. Manufactured under strict compliance with United States Pharmacopeia standards, PLPZOTUM guarantees exceptional purity, stability, and consistent therapeutic performance. Rigorous quality control protocols throughout the manufacturing process establish this product as a dependable solution for healthcare providers managing complex bacterial infections that require potent, reliable antibiotic intervention.

Healthcare institutions across multiple specialties extensively utilize PLPZOTUM for managing severe bacterial infections. The product sees significant application in intensive care units, emergency departments, surgical centers, and oncology wards where patients face heightened infection risks. Medical professionals in nephrology departments employ it for complicated urinary tract infections, while pulmonology units rely on its efficacy for respiratory infections. The antibiotic's comprehensive spectrum of activity makes it indispensable in multi-specialty hospitals and outpatient infusion centers. Additionally, advanced veterinary hospitals with sophisticated care capabilities incorporate this product for animal patients requiring powerful antibacterial treatment, demonstrating its versatility across medical domains.

PLPZOTUM delivers substantial value through its demonstrated reliability and consistent clinical performance. The product's uniform quality minimizes treatment failure risks, thereby enhancing patient outcomes and strengthening institutional credibility. Healthcare providers trust PLPZOTUM for its rapid antibacterial action, which contributes to reduced hospital stays and lower overall treatment expenditures. The product's compliance with international quality standards ensures seamless importation and distribution processes, reducing regulatory complications for suppliers. This reliability, combined with proven clinical effectiveness, positions PLPZOTUM as a smart investment for healthcare facilities prioritizing both patient care and operational efficiency.

Key Features:
- Each vial contains 4g Piperacillin and 500mg Tazobactam in precise formulation
- Easy reconstitution with 20ml sterile water for Injection IP
- Manufactured to United States Pharmacopeia quality standards
- Immediate administration capability after reconstitution
- Consistent potency and stability across production batches

Benefits:
- Comprehensive coverage against severe bacterial infections
- Rapid therapeutic action for critical care scenarios
- Reduced treatment failure risks through consistent quality
- Enhanced patient outcomes and recovery timelines
- Trusted reliability for healthcare professionals